Advance Care Planning Preferences in Older Adults with Lung Cancer
ACP GAME
+ acp manual
Bronchial Neoplasms+7
+ Carcinoma, Bronchogenic
+ Carcinoma, Non-Small-Cell Lung
Supportive Care Study
Summary
Study start date: September 22, 2024
Actual date on which the first participant was enrolled.This study focuses on improving communication and decision-making for older adults in Taiwan who have lung cancer, along with their families. Lung cancer has a high incidence and mortality rate, particularly affecting the elderly. Due to cultural norms, medical decisions in Taiwan are often made collectively by families rather than individually by patients. The study aims to address this issue by enhancing how patients and their potential surrogates discuss and agree on preferences for life-sustaining treatments, ensuring these decisions align with the patient's wishes. This is important as it can help avoid misunderstandings and ensure that the patient's autonomy and preferences are respected, potentially improving the quality of care they receive. The study explores different methods to encourage meaningful conversations between patients and their families about life-sustaining treatment preferences. By assessing current communication tools and possibly developing more engaging ways to discuss these important issues, the study measures whether these interventions increase the consistency of medical decisions with the patients' wishes. While it doesn't specify the exact methods used for these interventions, it highlights the need for strategies that are more appealing and effective than those currently available, like board games for Advance Care Planning. The goal is to find better ways to facilitate these critical discussions, ultimately improving patient care and satisfaction with medical decisions.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.120 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: 1. lung cancer age ≧ 60 2. The elderly with lung cancer are conscious and have no severe visual or hearing impairment. 3.3. The potential agent is designated by the elderly person with lung cancer who may be a family member who may make medical decisions in the future. The potential agent must be at least 18 years old. Exclusion Criteria: 1. People with severe hearing loss and visual impairment who are unable to communicate in Mandarin and Taiwanese. 2. The potential agent is under 18 years old
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
ExperimentalGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Taiwan University Hospital
Taipei, TaiwanOpen National Taiwan University Hospital in Google Maps